The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
Cancer Res. 2023 Mar 2;83(5):771-785. doi: 10.1158/0008-5472.CAN-22-1570.
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow-derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM.
Bone marrow-derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.
肿瘤相关巨噬细胞(TAM)在免疫抑制中起着至关重要的作用。然而,TAMs 如何转变为免疫抑制表型并影响肿瘤微环境(TME)尚不完全清楚。在这里,我们利用胶质母细胞瘤(GBM)组织的单细胞 RNA 测序和全外显子测序数据,鉴定出一小部分同时表达巨噬细胞和肿瘤特征的 TAMs,称为双阳性 TAMs。双阳性 TAMs 倾向于表达骨髓来源的巨噬细胞(BMDM),并具有免疫抑制表型特征。体外 BMDM 对胶质瘤细胞的吞噬作用产生了具有与患者 GBM TME 中双阳性 TAMs 相似的免疫抑制表型的双阳性 TAMs。双阳性 TAMs 被转化为 M2 样巨噬细胞,并通过表达免疫检查点蛋白 CD276、PD-L1 和 PD-L2 以及抑制活化 T 细胞的增殖来驱动免疫抑制。总之,TME 中的 BMDM 吞噬胶质瘤细胞导致具有增强的免疫抑制表型的双阳性 TAMs 的形成,揭示了驱动 GBM 中 TAM 介导的免疫抑制的过程。
骨髓来源的巨噬细胞吞噬胶质母细胞瘤细胞形成双阳性细胞,同时表达巨噬细胞和肿瘤特征,转化为 M2 样巨噬细胞并驱动免疫抑制。